| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
| mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |